Keywords
fallopian tube occlusion - recanalization - tubal infertility - women's health - interventional
radiology
Infertility is diagnosed when a biological female fails to become pregnant after 12
months of regular unprotected sexual intercourse (if younger than 35 years) or after
6 months (if aged 35 and above).[1] Primary infertility occurs in patients who have never had a documented pregnancy,
while secondary infertility occurs in patients who have previously had an established
pregnancy, regardless of the outcome.[2] Etiologies include uterine, tubal, ovarian, genetic, posttreatment, and systemic
pathologies.[3] Current estimates regarding the prevalence of infertility range from 7 to 15% but
it is likely higher.[4] Identifying and resolving treatable causes of infertility can save the patient time,
emotional and physical stress, and financial strain.
Tubal pathology accounts for up to 40% of cases of female infertility,[5] with proximal fallopian tube obstruction (FTO) in 10 to 25% cases.[6] The proximal fallopian tube or isthmus is very narrow in caliber, measuring approximately
1 mm in width, and is easily subject to total luminal occlusion as a result of mucus,
debris, or other pathologies.[7] The most common underlying pathology for proximal FTO is pelvic inflammatory disease
(PID) secondary to genital tract infections such as Neisseria gonorrhea or Chlamydia trachomatis.[5] The risk of infertility increases with the number and severity of infections.[8] Other causes include uterotubal spasm, mucous plugging/debris, endometriosis, lower
abdominal infection/inflammation (e.g., secondary to inflammatory bowel disease),
postsurgical scarring and adhesions, prior pelvic radiation, and pelvic tuberculosis.[5]
Diagnosing Fallopian Tube Obstruction
Diagnosing Fallopian Tube Obstruction
A thorough history and physical exam is the first step in evaluating infertility.
The patient may have a known history of prior sexually transmitted genital infection,
inflammatory bowel disease, or prior pelvic radiation, which can contribute to tubal
infertility.[5] Some underlying endocrine conditions can manifest physically with hirsutism, acne,
or thyromegaly and can be associated with infertility, but may not necessarily be
associated with an FTO.[5]
The gold standard for the diagnosis of FTO is laparoscopy with chromopertubation.[9] Colored fluid (dilute methylene blue, toluidine blue dye, indigo carmine, etc.)
is instilled into the uterus via a balloon catheter and the physician directly examines
the abdominal cavity for staining of the tubes and spillage into the peritoneal cavity,
indicating patency.[3]
[10] Laparoscopy also allows for evaluation of anatomic abnormalities such as hydrosalpinx
or tubal tortuosity, adhesive disease, and endometriosis.[8] Disadvantages of this procedure include invasiveness, need for anesthesia, cost,
and potential for subsequent development of new adhesions (which can further worsen
secondary infertility).[8]
[9]
Hysterosalpingography (HSG) is a minimally invasive option and commonly performed
as part of the infertility workup. The procedure entails instillation of radiopaque
contrast into the uterus via a balloon occlusion catheter and evaluating for peritoneal
spillage under fluoroscopy.[11]
[12] The benefit of HSG is that recanalization may be performed concurrently if a proximal
FTO is identified. Additionally, it can demonstrate other abnormalities that contribute
to infertility such as submucosal uterine fibroids, Müllerian anomalies, and mucosal
irregularities.[13] The main downside is radiation to the pelvis and gonadal structures; however, with
appropriate dose-reduction techniques, absorbed dose should be minimal.[14]
Hysterosalpingo-contrast-sonography (HyCoSy), also referred to as sonohysterography
(SHG), is an alternative to HSG and does not require radiation exposure to the patient.[15] Initial transvaginal ultrasound is performed to evaluate for hydrosalpinx or other
gross abnormalities.[9] Contrast is instilled into the uterine cavity via a balloon occlusion catheter under
sonographic visualization, allowing assessment of the endometrial cavity.[15] Common contrast agents include sterile saline, mixed air-saline, and ultrasound
contrast media such as Echovist (Schering AG, Berlin).[16] If at least one fallopian tube is patent, spilled contrast will be seen in the posterior
cul-de-sac.[3] The disadvantage of this procedure is that it is difficult to delineate laterality
in cases of unilateral FTO unless other imaging abnormalities are present (e.g., hydrosalpinx).
Additionally, visualization may be difficult depending on the location and contents
of adjacent bowel.
Fallopian Tube Recanalization: Indications and Contraindications
Fallopian Tube Recanalization: Indications and Contraindications
Fallopian tube recanalization (FTR) is indicated in patients with proximal FTO. Distal
occlusions of the tube are often related to pelvic adhesions or sequelae of PID and
are more appropriately treated by laparoscopy and tubal surgery.[17] FTR should not be performed in the setting of active pelvic infection, pregnancy,
uncontrolled uterine or vaginal bleeding, recent tubal or uterine surgery, or patients
with significant cardiac or renal dysfunction.[12] Allergy to contrast media is a relative contraindication, and oil-soluble contrast
media should not be used in patients with uncontrolled thyroid disease (due to risk
of transient hypothyroidism) or who are breastfeeding (due to risk of neonatal hypothyroidism).[3]
Fallopian Tube Recanalization Technique
Fallopian Tube Recanalization Technique
Preprocedure
The optimal timing for recanalization is during the proliferative phase of the menstrual
cycle, prior to ovulation; this is approximately at days 5 to 11 of the cycle.[3] During this period, the endometrium is thin, providing better visualization of the
contour.[12] The physician obtains informed consent and confirms the patient has a negative urine
pregnancy test on the day of procedure.
Antibiotic prophylaxis is not routinely recommended but should be administered in
patients with a history of PID or if the tubes are noted to be dilated at the time
of procedure as there is a small (1.5–3.5%) risk of developing postprocedural PID.[18] A 5-day course of doxycycline 100 mg BID can be started 2 days before the procedure
if these circumstances are known prior to FTR.[19]
[20] Alternatively, a single dose of doxycycline given preprocedurally has also been
shown to reduce the risk of infection.[18] Moderate sedation is administered at the discretion of the operator and may help
reduce uterotubal spasm.[1]
Procedural Technique
There are four steps to recanalization—uterine access, HSG, recanalization, and salpingography
([Fig. 1]).[21] Once in the procedural suite, the patient should be placed on the fluoroscopy table
in lithotomy position. Following preparation of the external genitalia and maximal
sterile draping, the operator inserts a sterile speculum into the vagina. Warming
the speculum can improve patient comfort and reduce uterotubal spasm; using a device
with an attached light may help visibility for the operator. Adequate visualization
is necessary to successfully cannulate the cervix. In cases of challenging cervical
cannulation, pressure on the speculum or utilization of a tenaculum to affix the cervix
may be necessary.[11]
[21] The cervix is then prepped with Betadine. Local anesthesia can be injected or topically
applied to the cervix at the discretion of the operator.[11]
Fig. 1 Basic steps for simultaneous assessment of tubal patency and fallopian tube recanalization.
OSCM, oil-soluble contrast medium; WSCM, water-soluble contrast medium; HSG, hysterosalpingography;
FTR, fallopian tube recanalization.
A balloon occlusion catheter or sheath is placed through the cervix into the uterine
cavity and the balloon is inflated. Dilute contrast is then slowly injected through
the catheter under fluoroscopy to perform an HSG. Gentle injection is recommended
to prevent uterotubal spasm and to ensure the tubes are not overdistended if there
is hydrosalpinx.[7] Possible findings include patent tubes with peritoneal contrast spillage, or obstruction
of one or both tubes either proximally or distally.
If a proximal FTO is observed ([Fig. 2]), selective catheterization of the culprit tubal ostium is performed.[22] This is achieved by placement of an angled or curved diagnostic catheter through
the balloon catheter or balloon-tip introducer sheath with the assistance of a hydrophilic
guidewire (typically 0.038-in diameter; [Fig. 3]).[7] In difficult cases, a microcatheter (3 Fr) and 0.018-in guidewire may be required
to traverse the occlusion. The Rösch-Thurmond Fallopian Tube Catheterization set is
available from Cook Medical (Cook Inc, Bloomington, IL) and contains all needed materials,
except for the 9-Fr intrauterine access balloon catheter (Cook Inc), which is available
separately ([Fig. 4]). After recanalization, salpingography is performed to confirm tubal patency ([Fig. 5]). While FTR can be performed alone after prior diagnosis of proximal FTO with HSG,
performing the HSG at the same time can decrease the overall radiation to the patient.[1]
Fig. 2 Hysterosalpingography demonstrating bilateral proximal tubal occlusion (arrows).
Fig. 3 Selective catheterization of the left tubal ostium with a 5-Fr angled catheter (arrow)
and passage of a 0.035-in hydrophilic guidewire (arrowhead) through the left fallopian
tube.
Fig. 4 Fallopian tube catheterization kit and intrauterine access balloon catheter from
Cook Medical (Cook Inc., Bloomington, IL).
Fig. 5 Post–fallopian tube recanalization salpingography demonstrating contrast in the left
fallopian tube (arrowheads) with intraperitoneal spillage (arrow).
Though recanalization can be attempted for distal FTO, these tend to be less technically
successful either due to hydrosalpinx or adhesions.[23]
Oil-Soluble versus Water-Soluble Contrast Media
Oil-Soluble versus Water-Soluble Contrast Media
A large prospective randomized controlled trial demonstrated a higher rate of post-HSG
pregnancy and live births following HSG with oil-soluble contrast media such as lipiodol
(Guerbet, France) compared to water-soluble contrast media and therefore oil-soluble
contrast should be used in infertile women with low risk for tubal pathology.[24] The mechanism is not clearly established, but proposed mechanisms include increased
hydrostatic pressure due to higher viscosity, resulting in clearing of mucous and
debris from the tube.[25] Oil-soluble contrast media have several disadvantages, including a higher rate of
intravasation with a small potential for oil embolization and poor visualization due
to high density of the fluid.[25] Oil-soluble contrast media are also more costly than water-soluble contrast media,
though still lower than the cost of in vitro fertilization.[24]
Postprocedural Management
Following recanalization, patients are briefly monitored if they have received sedation
and can be discharged with nonsteroidal anti-inflammatory medications. Patients can
expect a small amount of postprocedural discharge, spotting, and mild cramping for
1 to 2 days postprocedure.[21] Sexual intercourse can be resumed as soon as the patient has recovered from the
procedure.
Fallopian Tube Recanalization Outcomes
Fallopian Tube Recanalization Outcomes
Technical success of FTR can range up to 100%.[26] Post-FTR pregnancy rates are reported ranging from 12.8 to 51% in the literature,
averaging around 33%.[27]
[28] Successful conception is more likely in patients who require less intervention,
that is, can be recanalized with high-pressure contrast injection alone versus those
who require microcatheter/microwire manipulation to recanalize the tube.[6] The recognition that tubal flushing improves pregnancy rates in women undergoing
oil-soluble contrast media as compared to no-intervention was initially documented
in a Cochrane review, and these findings were later confirmed in a randomized controlled
trial comparing water-based and oil-based contrast during HSG for women with infertility,
with short- and long-term follow-up data.[24]
Time to conception is not frequently discussed in the literature and can be variable
as FTO may not be the sole cause of infertility in most patients. These patients may
require additional reproductive assistance (in vitro fertilization, intrauterine insemination,
ovulatory stimulation, etc.) and successfully conceive later.[17] One study of 72 patients mentions an average time to conception of 16.2 months.[29] Time to conception has been shown to be lower in patients who had FTR performed
with oil-soluble contrast media.[25]
Complications are overall rare after FTR and may include tubal perforation (2%), tubal
ectopic pregnancy (3%), and pelvic infection/PID (1%).[11] Reocclusion rates following FTR range from 20 to 50% at 6 months after recanalization.[7] Recanalization can be repeated multiple times if necessary; however, there is an
increased risk for tubal perforation.[6] A retrospective analysis by Shen et al establishes risk factors for tubal ectopic
pregnancy after FTR, including age 35 years or older, secondary infertility, 5 or
more years of duration of infertility, history of ectopic pregnancy, history of abdominal
surgery, and prior D&C.[28] A study of radiation dose during FTR reported an average procedural fluoroscopy
time of 8.5 minutes with average radiation exposure less than 1 rad (10 mGy),[14] well below threshold for causing significant deterministic effects.
Conclusion
Fallopian tube recanalization has been utilized as an adjunct treatment of infertility
for over 30 years; yet, its utilization depends on patient referrals and access to
subspecialized IR care.[30] However, given the procedure is low in cost and invasiveness and has a high technical
success rate, FTR should be offered to infertile patients with proximal FTO, regardless
of whether they subsequently require additional reproductive assistance to conceive.
